HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Restoration of vision in the pde6β-deficient dog, a large animal model of rod-cone dystrophy.

Abstract
Defects in the β subunit of rod cGMP phosphodiesterase 6 (PDE6β) are associated with autosomal recessive retinitis pigmentosa (RP), a childhood blinding disease with early retinal degeneration and vision loss. To date, there is no treatment for this pathology. The aim of this preclinical study was to test recombinant adeno-associated virus (AAV)-mediated gene addition therapy in the rod-cone dysplasia type 1 (rcd1) dog, a large animal model of naturally occurring PDE6β deficiency that strongly resembles the human pathology. A total of eight rcd1 dogs were injected subretinally with AAV2/5RK.cpde6β (n = 4) or AAV2/8RK.cpde6β (n = 4). In vivo and post-mortem morphological analysis showed a significant preservation of the retinal structure in transduced areas of both AAV2/5RK.cpde6β- and AAV2/8RK.cpde6β-treated retinas. Moreover, substantial rod-derived electroretinography (ERG) signals were recorded as soon as 1 month postinjection (35% of normal eyes) and remained stable for at least 18 months (the duration of the study) in treated eyes. Rod-responses were undetectable in untreated contralateral eyes. Most importantly, dim-light vision was restored in all treated rcd1 dogs. These results demonstrate for the first time that gene therapy effectively restores long-term retinal function and vision in a large animal model of autosomal recessive rod-cone dystrophy, and provide great promise for human treatment.
AuthorsLolita Petit, Elsa Lhériteau, Michel Weber, Guylène Le Meur, Jack-Yves Deschamps, Nathalie Provost, Alexandra Mendes-Madeira, Lyse Libeau, Caroline Guihal, Marie-Anne Colle, Philippe Moullier, Fabienne Rolling
JournalMolecular therapy : the journal of the American Society of Gene Therapy (Mol Ther) Vol. 20 Issue 11 Pg. 2019-30 (Nov 2012) ISSN: 1525-0024 [Electronic] United States
PMID22828504 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA, Messenger
  • Cyclic Nucleotide Phosphodiesterases, Type 6
Topics
  • Animals
  • Cyclic Nucleotide Phosphodiesterases, Type 6 (deficiency, genetics)
  • Dependovirus (genetics)
  • Disease Models, Animal
  • Dogs
  • Electroretinography
  • Genetic Therapy
  • Genetic Vectors
  • Humans
  • RNA, Messenger (genetics, metabolism)
  • Recovery of Function
  • Retina (metabolism, pathology, physiopathology)
  • Retinal Vessels (pathology)
  • Retinitis Pigmentosa (physiopathology, therapy)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transgenes
  • Treatment Outcome
  • Vision, Ocular

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: